{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:12:08Z","timestamp":1779297128513,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015384","name":"Prostate Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015384","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004622","name":"KWF Dutch Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejca.2026.116741","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T17:37:12Z","timestamp":1776015432000},"page":"116741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prostate cancer mortality among men with and without comorbidity: Long-term results from the European randomized study of screening for prostate cancer Rotterdam"],"prefix":"10.1016","volume":"240","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5780-6625","authenticated-orcid":false,"given":"Sanne F.","family":"Westerhout","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9530-6448","authenticated-orcid":false,"given":"Sebastiaan","family":"Remmers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris H.","family":"Bangma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2176-9102","authenticated-orcid":false,"given":"Geert J.L.H.","family":"van Leenders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pim J.","family":"van Leeuwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique J.","family":"Roobol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10437","key":"10.1016\/j.ejca.2026.116741_bib1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet Commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ejca.2026.116741_bib2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7326\/M16-2586","article-title":"Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO Trials","volume":"167","author":"Tsodikov","year":"2017","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.ejca.2026.116741_bib3","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1056\/NEJMoa2503223","article-title":"European study of prostate cancer screening - 23-Year Follow-up","volume":"393","author":"Roobol","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejca.2026.116741_bib4","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.eururo.2019.02.009","article-title":"A 16-yr Follow-up of the European randomized study of screening for prostate cancer","volume":"76","author":"Hugosson","year":"2019","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ejca.2026.116741_bib5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/JU.0000000000002696","article-title":"Results from 22 years of followup in the g\u00f6teborg randomized population-based prostate cancer screening trial","volume":"208","author":"Fr\u00e5nlund","year":"2022","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116741_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.eururo.2023.03.016","article-title":"A detailed evaluation of the effect of prostate-specific antigen-based screening on morbidity and mortality of prostate cancer: 21-year follow-up results of the rotterdam section of the european randomised study of screening for prostate cancer","volume":"84","author":"de","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejca.2026.116741_bib7","unstructured":"Council E. Council updates its recommendation to screen for cancer. European Council; 2022."},{"issue":"9959","key":"10.1016\/j.ejca.2026.116741_bib8","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schr\u00f6der","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ejca.2026.116741_bib9","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1113135","article-title":"Prostate-cancer mortality at 11 years of follow-up","volume":"366","author":"Schr\u00f6der","year":"2012","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ejca.2026.116741_bib10","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejca.2026.116741_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1465-5101.2003.04402.x","article-title":"Determining the cause of death in randomized screening trial(s) for prostate cancer","volume":"92","author":"De Koning","year":"2003","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ejca.2026.116741_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","article-title":"How to measure comorbidity. a critical review of available methods","volume":"56","author":"de Groot","year":"2003","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.ejca.2026.116741_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"10","key":"10.1016\/j.ejca.2026.116741_bib14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.7326\/0003-4819-159-10-201311190-00005","article-title":"Comorbidity-adjusted life expectancy: a new tool to inform recommendations for optimal screening strategies","volume":"159","author":"Cho","year":"2013","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ejca.2026.116741_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/oxfordjournals.aje.a114001","article-title":"Use of poisson regression models in estimating incidence rates and ratios","volume":"121","author":"FROME","year":"1985","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejca.2026.116741_bib16","unstructured":"Commission O.E. Health at a Glance: Europe 2024: State of Health in the EU Cycle. Paris; 2024."},{"issue":"4","key":"10.1016\/j.ejca.2026.116741_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1200\/JCO.2010.30.5979","article-title":"Comorbidity and mortality results from a randomized prostate cancer screening trial","volume":"29","author":"Crawford","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116741_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/21681805.2017.1411392","article-title":"Eighteen-year follow-up of the g\u00f6teborg randomized population-based prostate cancer screening trial: effect of sociodemographic variables on participation, prostate cancer incidence and mortality","volume":"52","author":"Hugosson","year":"2018","journal-title":"Scand J Urol"},{"issue":"6","key":"10.1016\/j.ejca.2026.116741_bib19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.eururo.2019.03.010","article-title":"Could Differences in treatment between trial arms explain the reduction in prostate cancer mortality in the european randomized study of screening for prostate cancer?","volume":"75","author":"Carlsson","year":"2019","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ejca.2026.116741_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.eururo.2014.10.008","article-title":"Differences in treatment and outcome after treatment with curative intent in the screening and control arms of the ERSPC Rotterdam","volume":"68","author":"Bokhorst","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejca.2026.116741_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.euo.2025.12.004","article-title":"Effects of causal and noncausal components of screening on prostate cancer mortality: a mediation analysis from the Dutch, Finnish, and Swedish Centers of the European randomized study of screening for prostate cancer","author":"Remmers","year":"2026","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116741_bib22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.juro.2010.10.061","article-title":"Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden","volume":"185","author":"Berglund","year":"2011","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116741_bib23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.eururo.2024.07.019","article-title":"Prostate cancer early detection in the European Union and UK","volume":"87","author":"Leenen","year":"2025","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ejca.2026.116741_bib24","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. part i: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926005228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T16:22:18Z","timestamp":1779294138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926005228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":24,"alternative-id":["S0959804926005228"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116741","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer mortality among men with and without comorbidity: Long-term results from the European randomized study of screening for prostate cancer Rotterdam","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116741"}}